News

Craig C. Hopkinson, the EVP R&D of $ALKS, sold 100,918 shares of the company on 01-30-2025 for an estimated $3,234,381. We received data on the trade from a recent SEC filing. This was a sale of approximately 69.5% of their shares of this class of stock. Following this trade, they now own 44,290 shares of this class of $ALKS stock.

$ALKS Insider Trading Activity

$ALKS insiders have traded $ALKS stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $ALKS stock by insiders over the last 6 months:

• CRAIG C. HOPKINSON (EVP R&D, Chief Medical Officer) has made 0 purchases and 6 sales selling 255,106 shares for an estimated $8,011,544.
• CHRISTIAN TODD NICHOLS (SVP, Chief Commercial Officer) sold 5,208 shares for an estimated $151,813
• CATO T LAURENCIN sold 2,691 shares for an estimated $85,708

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ALKS Hedge Fund Activity

We have seen 165 institutional investors add shares of $ALKS stock to their portfolio, and 157 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 1,986,294 shares (+18.0%) to their portfolio in Q3 2024, for an estimated $55,596,369
• WELLINGTON MANAGEMENT GROUP LLP removed 1,696,507 shares (-11.8%) from their portfolio in Q3 2024, for an estimated $47,485,230
• COMMODORE CAPITAL LP added 1,525,000 shares (+110.9%) to their portfolio in Q3 2024, for an estimated $42,684,750
• LOOMIS SAYLES & CO L P added 1,478,422 shares (+365.5%) to their portfolio in Q3 2024, for an estimated $41,381,031
• WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,316,605 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $36,851,773
• ARMISTICE CAPITAL, LLC removed 1,250,525 shares (-46.3%) from their portfolio in Q3 2024, for an estimated $35,002,194
• AMERICAN CENTURY COMPANIES INC added 1,037,511 shares (+47.1%) to their portfolio in Q3 2024, for an estimated $29,039,932

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.